Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Pablo Cagnoni Insider Profile

4 Followers

Pablo Cagnoni, President, Global Head of R&D at Incyte, holds 183.20K shares in Incyte (Ticker: INCY), holds 0.00 shares in Onyx Pharma (Ticker: ONXX), holds 66.08K shares in Rubius Therapeutics (Ticker: RUBY).

Pablo Cagnoni's Trading History

INCYIncyte		Oct 19, 2026President, Global Head of R&DUninformative Buy173.74K$22.06M
RUBYRubius Therapeutics		Feb 01, 2023―Uninformative Sell2.11K$3.77K
CRSPCrispr Therapeutics AG		Nov 21, 2019DirectorUninformative Buy41.92K$0.00
FUSNFusion Pharmaceuticals		――――
ONXXOnyx Pharma		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Pablo Cagnoni insider profile FAQ

What is the percentage of profitable transactions made by Pablo Cagnoni?
The percentage of profitable transactions made by Pablo Cagnoni is 50%.
What is the average return per transaction made by Pablo Cagnoni?
The average return per transaction made by Pablo Cagnoni is 36.70%.
What stocks does Pablo Cagnoni hold?
Pablo Cagnoni holds: INCY, ONXX, CRSP, RUBY, FUSN stocks.
What was Pablo Cagnoni’s latest transaction?
Pablo Cagnoni’s latest transaction was an Uninformative Buy of $173.74K.
What was Pablo Cagnoni's most profitable transaction?
Pablo Cagnoni’s most profitable transaction was an Informative Buy of RUBY stock on April 15, 2020. The return on the trade was 436.80%.
What is Pablo Cagnoni's role in Incyte?
Pablo Cagnoni's role in Incyte is President, Global Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.